Language selection

Search

Patent 2335271 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2335271
(54) English Title: COMPOSITIONS, PROCESSES AND METHODS OF IMPROVING THE WEAR RESISTANCE OF PROSTHETIC MEDICAL DEVICES
(54) French Title: COMPOSITIONS, PROCESSUS ET METHODES D'AMELIORATION DE LA RESISTANCE A L'USURE DE PROTHESES MEDICALES
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • C08L 23/06 (2006.01)
  • A61L 02/20 (2006.01)
  • A61L 27/16 (2006.01)
  • A61L 27/26 (2006.01)
  • C08J 03/24 (2006.01)
  • C08J 03/28 (2006.01)
  • C08J 05/00 (2006.01)
(72) Inventors :
  • WANG, AIGUO (United States of America)
  • ESSNER, AARON (United States of America)
(73) Owners :
  • HOWMEDICA OSTEONICS CORP.
(71) Applicants :
  • HOWMEDICA OSTEONICS CORP. (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 2008-07-15
(22) Filed Date: 2001-02-12
(41) Open to Public Inspection: 2001-08-29
Examination requested: 2001-02-12
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
09/515,877 (United States of America) 2000-02-29

Abstracts

English Abstract

Methods and compositions for fabricating prosthetic medical devices exhibiting improved wear resistance include selectively cross-linking polymeric resins then curing and shaping the polymer into a finished article. The selectively cross- linked polymeric compositions may be created by blending a specific amount of cross--linked resins with a specific amount of uncross-linked resins then cured into a polymeric matrix whereby the desired degree or percentage of overall cross- linking is obtained. The polymeric material may then be formed directly into a finished article by injection molding the polymeric material.


French Abstract

Méthodes et compositions pour fabriquer des prothèses médicales ayant une meilleure résistance à l'usure, notamment en réticulant sélectivement des résines polymères, puis en traitant et en façonnant le polymère en un article fini. Les compositions polymères sélectivement réticulées peuvent être créées en mélangeant une quantité spécifique de résines réticulées avec une quantité spécifique de résines non réticulées, qui sont ensuite traitées pour donner une matrice polymère permettant d'obtenir le degré ou le pourcentage désirés de réticulation globale. Le matériel polymère peut ensuite être façonné directement en un article fini par moulage par injection du matériel polymère.

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS:
A prosthetic medical device comprising:
a) a cured polymeric substance produced from a blended mixture of at least
one cross-linked and at least one non-crosslinked polyolefinic resin(s).
2. The prosthetic medical device according to claim 1 wherein said crosslinked
and non-crosslinked polyolefinic resins are selected from the group comprising
PE,
PP, HMWPE, HMWPP, HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
3. The prosthetic medical device according to claim 1 wherein said cross-
linked
and non-cross-linked polyolefinic resins are UHMWPE.
4. The prosthetic medical device according to claim 1 wherein said cross-
linked
polyolefinic resin(s) are produced by exposing said resin(s) to an irradiation
source.
5. The prosthetic medical device according to claim 4 wherein said resin(s)
are
contained in an inert environment.
6. The prosthetic medical device according to claim 1 wherein the device is in
the shape of components of implantable-devices selected from the group
comprising
components of implants for a shoulder, an elbow, an ankle, a wrist, a finger,
a jaw, a
hip, a knee, and a vertebra.
7. The prosthetic medical device in claim 1 wherein the device a load-bearing
orthopedic implant.
8. The prosthetic medical device according to claim 1 wherein said cured
polymeric substance has been injection molded.
9. The prosthetic medical device of claim 1 wherein said at least one cross-
linked polyolefinic resin is UHMWPE and said at least one non-crosslinked
polyolefinic resin is HDPE.
-14-

10. A polymeric composition for fabricating prosthetic medical devices
comprising:
a) one or more non-cross-linked polyolefinic resin(s); and
b) one or more cross-linked polyolefinic resin(s) whereby said resins are
blended and cured into a polymeric article.
11. The composition of claim 10 wherein said non-cross-linked polyolefinic
resin(s) are selected from the group comprising PE, PP, HMWPE, HMWPP, HDPE,
HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
12. The composition of claim 10 wherein said cross-linked polyolefinic
resin(s)
are selected from the group comprising PE, PP, HMWPE, HMWPP, LDPE, LDPP,
UHMWPE and UHMWPP.
13. The composition of claim 10 wherein said cross-linked polyolefin resin has
a
molecular weight between 1,000 - 10,000,000.
14. The composition of claim 10 wherein said non-cross-linked polyolefin resin
has a molecular weight between 1,000 - 10,000,000.
15. The composition of claim 10 wherein said cross-linked polyolefin was
produced by gamma, electron beam or x-ray irradiation.
16. The composition of claim 10, wherein said cross-linked polyolefinic resin
is
present in amounts between 1% to 99%.
17. The composition of claim 10 wherein said cross-linked and non-cross-linked
polyolefinic resins are blended to homogeneity.
18. The composition of claim 10 wherein said polyolefinic resins are injection
molded.
-15-

19. The composition of claim 11, wherein said non-
cross-linked polyolefinic resin is UHMWPE.
20. The composition of claim 12, wherein said cross-
linked polyolefinic resin is UHMWPE.
21. The composition of claim 16, wherein said cross-
linked polyolefinic resin is present in a ratio of 50:50
cross-linked to non-cross-linked polyolefinic resin.
22. The composition of claim 16, wherein said cross-
linked polyolefinic resin is present in a ratio of 30:70
cross-linked to non-cross-linked polyolefinic resin.
23. The composition of claim 10, wherein one of said
cross-linked and non-cross-linked polyolefinic resins is
UHMWPE and the other of said cross-linked and non-cross-
linked polyolefinic resins is HDPE.
24. The composition of claim 23, wherein said cross-
linked polyolefinic resin is UHMWPE and said non-cross-
linked polyolefinic resin is HDPE.
25. The composition of claim 23, wherein said UHMWPE
is present in a ratio of 1:99 UHMWPE to HDPE.
26. The composition of claim 23, wherein said UHMWPE
is present in a ratio of 20:80 UHMWPE to HDPE.
27. The composition of claim 23, wherein said UHMWPE
is present in a ratio of 30:70 UHMWPE to HDPE.
28. The composition of any one of claims 23 to 27,
wherein said polyolefinic resins are injection molded.
29. A method of fabricating a bearing surface
comprising:
-16-

blending a non-cross-linked polyolefinic material
with cross-linked polyolefinic material to form a blended
material; and
forming the bearing surface from the blended
material.
30. The method of claim 29, wherein the step of
blending comprises blending non-cross-linked and cross-
linked polyolefinic material selected from the group
comprising PE, PP, HMWPE, HMWPP, HDPE, HDPP, LDPE, LDPP,
UHMWPE and UHMWPP.
31. The method of claim 29, wherein the step of
blending comprises blending non-cross-linked polyolefinic
material selected from the group comprising PE, PP, HMWPE,
HMWPP, HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
32. The method of claim 29, wherein the step of
blending comprises blending cross-linked polyolefinic
material selected from the group comprising PE, PP, HMWPE,
HMWPP, HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
33. The method of claim 29, wherein the crossed-linked
polyolefinic material has an average molecular weight
between 1,000-10,000,000.
34. The method of claim 29, wherein the non-crossed-
linked polyolefinic material has an average molecular weight
between 1,000-10,000,000.
35. The method of claim 29, wherein the cross-linked
polyolefinic material was produced by gamma, electron beam
or x-ray irradiation.
-17-

36. The method of claim 29, wherein the cross-linked
polyolefinic material is present in amounts between 1% to
99%.
37. The method of claim 29, wherein the cross-linked
and non-cross-linked polyolefinic material are blended to
homogeneity.
38. The method of claim 31, wherein the non-cross-
linked polyolefinic material is UHMWPE.
39. The method of claim 32, wherein the cross-linked
polyolefinic material is UHMWPE.
40. The method of claim 36, wherein the cross-linked
polyolefinic material is present in a ratio of 50:50 cross-
linked to non-cross-linked polyolefinic material.
41. The method of claim 36, wherein the cross-linked
polyolefinic material is present in a ratio of 30:70 cross-
linked to non-cross-linked polyolefinic material.
42. The method of claim 30, wherein one of the cross-
linked and non-cross-linked polyolefinic material is UHMWPE
and the other of the cross-linked and non-cross-linked
polyolefinic material is HDPE.
43. The method of claim 42, wherein the cross-linked
polyolefinic material is UHMWPE and the non-cross-linked
polyolefinic material is HDPE.
44. The method of claim 42, wherein the UHMWPE is
present in a ratio of 1:99 UHMWPE to HDPE.
45. The method of claim 42, wherein the UHMWPE is
present in a ratio of 20:80 UHMWPE to HDPE.
-18-

46. The method of claim 42, wherein the UHMWPE is
present in a ratio of 30:70 UHMWPE to HDPE.
47. The method of any one of claims 42 to 46, wherein
the blended material is injection molded.
48. The method of claim 29, wherein the non-cross-
linked and cross-linked polyolefinic material are in resin
form.
49. The method of claim 29, wherein the non-cross-
linked and cross-linked polyolefinic material are in powder
form.
50. The method of claim 29, wherein the non-cross-
linked and cross-linked polyolefinic material are in pellet
form.
51. The method of claim 29, wherein the non-cross-
linked and cross-linked polyolefinic material are in flake
form.
52. The method of claim 29, wherein the bearing
surface is formed by subjecting the blended material to an
extrusion device.
53. The method of claim 29, wherein the bearing
surface is formed by subjecting the blended material to a
compression molding device.
54. The method of claim 29, wherein the bearing
surface is formed by subjecting the blended material to an
injection molding device.
55. The method of claim 29, wherein the cross-linked
polyolefinic material is produced by sealing non-cross-
linked polyolefinic material in an inert atmosphere to
-19-

define a sealed material and exposing the sealed material to
an irradiation source to obtain a desired level of cross-
linking.
56. The method of claim 55, wherein the sealed
material is annealed at an elevated temperature in the inert
atmosphere after being exposed to the irradiation source.
57. The method of claim 29, wherein the blended
material is formed into a workpiece prior to forming the
bearing surface.
58. The method of claim 57, further comprising shaping
the workpiece into a prosthetic medical device comprising
the bearing surface.
59. The method of claim 58, wherein the step of
shaping the workpiece further comprises shaping the
workpiece into a component for an orthopedic implant
selected from the group of implants for shoulders, elbows,
ankles, wrists, fingers, jaws, hips, knees and vertebra.
60. The method of claim 29, wherein the step of
shaping the workpiece further comprises shaping the
workpiece into load-bearing orthopedic implants.
61. A method of fabricating a polyolefinic bearing
surface comprising:
cross-linking a polyolefinic material;
blending the cross-linked polyolefinic material
with non-cross-linked material to form a blended material;
and
forming the bearing surface from the blended
material.
-20-

62. The method of claim 61, wherein the polyolefinic
material is selected from the group comprising PE, PP,
HMWPE, HMWPP, HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
63. The method of claim 61, wherein the cross-linked
polyolefinic material is produced by gamma, electron beam or
x-ray irradiation.
64. The method of claim 61, wherein the step of cross-
linking the polyolefinic material comprises sealing non-
cross-linked polyolefinic material in an inert atmosphere to
define a sealed material and exposing the sealed material to
an irradiation source to obtain a desired level of cross-
linking.
65. The method of claim 64, wherein the sealed
material is annealed at an elevated temperature in the inert
atmosphere after being exposed to the irradiation source.
66. A method of fabricating a polyolefinic bearing
surface comprising:
providing polyolefinic material;
cross-linking a portion of the polyolefinic
material;
blending the cross-linked polyolefinic material
with non-cross-linked polyolefinic material to form a
blended material; and
forming the bearing surface from the blended
material.
67. The method of claim 66, wherein the polyolefinic
material is selected from the group comprising PE, PP,
HMWPE, HMWPP, HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
-21-

68. The method of claim 66, wherein the cross-linked
polyolefinic material is produced by gamma, electron beam or
x-ray irradiation.
69. The method of claim 66, wherein the step of cross-
linking a portion of the polyolefinic material comprises
sealing non-cross-linked polyolefinic material in an inert
atmosphere to define a sealed material and exposing the
sealed material to an irradiation source to obtain a desired
level of cross-linking.
70. The method of claim 69, wherein the sealed
material is annealed at an elevated temperature in the inert
atmosphere after being exposed to the irradiation source.
71. A prosthetic medical device fabricated by a
process comprising the steps of:
a) irradiating at least one polymeric resin in the
presence of an inert atmosphere to yield a cross-linked
irradiated polymeric resin;
b) blending at least one non-irradiated polymer
with said at least one irradiated polymeric resin to form a
blended mixture;
c) forming a cured workpiece from said blended
mixture; and
d) shaping said workpiece into a prosthetic
medical device.
72. The prosthetic medical device of claim 71
fabricated into a load-bearing medical device.
73. The prosthetic medical device of claim 71 shaped
into component for an orthopedic implant selected from the
-22-

group of implants for shoulders, elbows, ankles, wrists,
fingers, jaws, hips, knees and vertebra.
74. The prosthetic medical device of claim 71 shaped
into component for an orthopedic implant selected from the
group of implants for load-bearing orthopedic implants.
75. The prosthetic medical device of claim 71 wherein
said irradiated and non-irradiated polymeric resins are the
same or different types of polymer substrates.
76. The prosthetic medical device of claim 71 wherein
said irradiated and non-irradiated polymeric resins are
selected from the group comprising PE, PP, HMWPE, HMWPP,
HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
77. The prosthetic medical device of claim 71 wherein
the irradiated polymer is irradiated UHMWPE and the non-
irradiated polymer is non-irradiated HDPE.
78. A prosthetic medical device fabricated by a
process comprising the steps of:
a) irradiating at least one polymeric resin in the
presence of an inert atmosphere to yield a cross-linked
irradiated polymeric resin;
b) blending at least one non-irradiated polymer
with said at least one irradiated polymeric resin to form a
blended mixture; and
c) forming a prosthetic medical device by
injection molding the blended mixture.
79. A prosthetic medical device having improved wear
resistance comprising: an irradiated polymer and a non-
-23-

irradiated polymer blended as a mixture, injection molded
and cured into a finished article or workpiece.
80. The prosthetic medical device of claim 79 wherein
the irradiated and non-irradiated polymers are selected from
the group comprising PE, PP, HMWPE, HMWPP, HDPE, HDPP, LDPE,
LDPP, UHMWPE and UHMWPP.
81. The prosthetic medical device of claim 79 shaped
into a component for an orthopedic implant selected from the
group of implants for shoulders, elbows, ankles, wrists,
fingers, jaws, hips, knees and vertebra.
82. The prosthetic medical device of claim 79 shaped
into a component for an orthopedic implant selected from the
group of implants for load-bearing orthopedic prosthetic
medical devices.
83. The prosthetic medical device of claim 79 further
comprising lubricants, dyes, fillers, buffers or free
radical inhibitors.
84. A prosthetic medical device fabricated by a
process comprising the steps of:
a) irradiating at least one polyolefinic material
in the presence of an inert atmosphere to yield a cross-
linked irradiated polyolefinic material;
b) blending at least one non-irradiated
polyolefinic material with the at least one irradiated
polyolefinic material to form a blended material; and
c) forming the prosthetic medical device from the
blended material.
-24-

85. The prosthetic medical device of claim 84, wherein
the irradiation is followed by stabilization of the at least
one irradiated polyolefinic material.
86. The prosthetic medical device of claim 85, wherein
the stabilization comprises heating the at least one
irradiated polyolefinic material.
87. The prosthetic medical device of claim 85, wherein
the stabilization comprises heating the at least one
irradiated polyolefinic material in an inert atmosphere.
88. The prosthetic medical device of claim 85, wherein
the stabilization reduces free radicals created by the
irradiation to acceptable levels.
89. The prosthetic medical device of claim 87, wherein
the at least one irradiated polyolefinic material is
stabilized using heat in an inert atmosphere at an elevated
temperature ranging from approximately 100°C - 150°C for
three days.
90. The prosthetic medical device of claim 87, wherein
the stabilization is followed by ambient cooling.
91. The prosthetic medical device of claim 84, wherein
the formed prosthetic medical device of step c) is
thereafter sterilized.
92. The prosthetic medical device of claim 91, wherein
the formed prosthetic medical device is sterilized by gas
plasma or ethylene oxide.
93. The prosthetic medical device of claim 91, wherein
the formed prosthetic medical device is sterilized by
further irradiation treatment.
-25-

94. The prosthetic medical device of claim 84,
fabricated into a load-bearing medical device.
95. The prosthetic medical device of claim 84, wherein
the irradiated and non-irradiated polyolefinic material are
selected from the group comprising PE, PP, HMWPE, HMWPP,
HDPE, HDPP, LDPE, LDPP, UHMWPE and UHMWPP.
96. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is selected from the
group comprising PE, PP, HMWPE, HMWPP, HDPE, HDPP, LDPE,
LDPP, UHMWPE and UHMWPP.
97. The prosthetic medical device of claim 84, wherein
the non-irradiated polyolefinic material is selected from
the group comprising PE, PP, HMWPE, HMWPP, HDPE, HDPP, LDPE,
LDPP, UHMWPE and UHMWPP.
98. The prosthetic medical device of claim 84, wherein
the at least one irradiated polyolefinic material is
produced by gamma, electron beam or x-ray irradiation.
99. The prosthetic medical device of claim 84, wherein
the irradiated and non-irradiated polyolefinic material are
the same or different types of polymer substrates.
100. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is present in amounts
between 1% to 99% in the blended material.
101. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material and the non-irradiated
polyolefinic material are blended to homogeneity.
102. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is UHMWPE.
-26-

103. The prosthetic medical device of claim 84, wherein
the non-irradiated polyolefinic material is UHMWPE.
104. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is present in the
blended material in a ratio of 50:50 irradiated to non-
irradiated polyolefinic material.
105. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is present in the
blended material in a ratio of 30:70 irradiated to non-
irradiated polyolefinic material.
106. The prosthetic medical device of claim 84, wherein
one of the irradiated and non-irradiated polyolefinic
material is UHMWPE and the other of the irradiated and non-
irradiated polyolefinic material is HDPE.
107. The prosthetic medical device of claim 106,
wherein the irradiated polyolefinic material is UHMWPE and
the non-irradiated polyolefinic material is HDPE.
108. The prosthetic medical device of claim 107,
wherein the UHMWPE is present in a ratio of 1:99 UHMWPE to
HDPE.
109. The prosthetic medical device of claim 107,
wherein the UHMWPE is present in a ratio of 20:80 UHMWPE to
HDPE.
110. The prosthetic medical device of claim 107,
wherein the UHMWPE is present in a ratio of 30:70 UHMWPE to
HDPE.
111. The prosthetic medical device of any one of
claims 104 to 110, wherein the blended material is injection
molded.
-27-

112. The prosthetic medical device of claim 84, wherein
the polyolefinic material is in resin form.
113. The prosthetic medical device of claim 84, wherein
the polyolefinic material is in powder form.
114. The prosthetic medical device of claim 84, wherein
the polyolefinic material is in pellet form.
115. The prosthetic medical device of claim 84, wherein
the polyolefinic material is in flake form.
116. The prosthetic medical device of claim 84, wherein
the prosthetic medical device is formed by subjecting the
blended material to an extrusion device.
117. The prosthetic medical device of claim 84, wherein
the prosthetic medical device is formed by subjecting the
blended material to a compression molding device.
118. The prosthetic medical device of claim 84, wherein
the prosthetic medical device is formed by subjecting the
blended material to an injection molding device.
119. The prosthetic medical device of claim 84, wherein
the irradiated polyolefinic material is annealed at an
elevated temperature in the inert atmosphere after being
exposed to the irradiation source.
120. The prosthetic medical device of claim 84 shaped
into a component for an orthopedic implant selected from the
group of implants for shoulders, elbows, ankles, wrists,
fingers, jaws, hips, knees and vertebra.
121. The prosthetic medical device of claim 84, further
comprising a compound selected from the group consisting of
-28-

lubricants, dyes, fillers, buffers and free radical
inhibitors.
122. A prosthetic medical device fabricated by a
process comprising the steps of:
a) irradiating at least one polyolefinic material
in the presence of an inert atmosphere;
b) stabilizing the at least one irradiated
polyolefinic material to yield a cross-linked irradiated
polyolefinic material;
c) blending at least one non-irradiated
polyolefinic material with the at least one cross-linked
irradiated polyolefinic material; and
d) forming the prosthetic medical device from the
blended material.
123. A prosthetic medical device fabricated by a
process comprising the steps of:
a) irradiating at least one polyolefinic material
in the presence of an inert atmosphere;
b) forming cross-links between free radicals by
using heat in an inert atmosphere to yield a cross-linked
irradiated polyolefinic material;
c) blending at least one non-irradiated
polyolefinic material with the at least one cross-linked
irradiated polyolefinic material; and
d) forming the prosthetic medical device from the
blended material.
-29-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02335271 2001-02-12
COMPOSITIONS, PROCESSES AND METHODS OF IMPROVING THE WEAR
RESISTANCE OF PROSTHETIC MEDICAL DEVICES
FIELD OF THE INVENTION
The present invention relates to polymeric compositions and methods
of making the same for use in fabricating prosthetic medical devices, as well
as
prosthetic devices made at least partially therefrom with improved wear
resistance.
BACKGROUND OF THE INVENTION
Many prosthetic medical devices are implanted into load-bearing
joints such as knees, hips, etc. As such, these prosthetic devices must be
very strong
and possess a high degree of wear resistance. Presently, the prosthetic
medical
device industry has utilized various metals and polymers and combinations
thereof to
t~ fabricate prosthetic devices. Unfortunately, both metals and polymers llave
drawbacks. For example, metals such as stainless steel, tungsten and titanium,
and
alloys thereof, may succumb to the corrosive environment of the body and
eventuallv
begin to wear. Such wear may result in fine metallic particles being scraped
away
from the contact surface of the device and into surrounding tissue and bone
which
?o may potentially cause pathogenic problems. Polymers, such as polyethylene,
polypropylene and nylons may also exhibit wear and may consequently produce
particles which diffuse into tissue and bone. Both metallic and polymeric
particles
shed from these prosthetic medical devices are of concern because they may be
inherently reactive with the tissue and bone they contact, thus possibly
causing tissue
25 degradation or necrosis.
Various methods have been devised attempting to reduce the wear rate
of the load bearing prosthetic medical devices. For polymers, a common
practice

CA 02335271 2001-02-12
~ i
within the prosthetic medical device industry is to use cross-linked polvmers
and
resins to form the medical device. Polymers are commonly cross-linked by
chemical
catalysis or irradiation exposure. Most cross-linking methodologies do result
in
greater wear resistance. However, indiscriminate or uncontrolled cross-linking
may
result in the formation of a weakened polymeric matrix, not capable of
withstanding
the enormous pressures placed on the devices in the patient resulting in
degradative
wear as described above.
Another difficulty conventionally encountered in the manufacturing
process of prosthetic medical devices is that they cannot be formed by
inexpensive
injection molding techniques. Instead, these medical devices must be formed by
extrusion, for example, which requires further machining into the finished
article.
Injection molding, on-the-other-hand, allows for the final article to be
formed in
virtually one step.
Therefore, a need exists within the prosthetic medical device industry
to fabricate an improved polymeric prosthetic device possessing sufficient
strength to
withstand the stress and pressure imposed on it, yet resist wear so that
foreign
particles liberated from the prosthetic device do not cause health problems to
the
patient. There also exists a need to fabricate the devices inexpensively by
injection
molding. The present invention provides compositions, as well as methods of
improving the wear resistance of prosthetic medical devices, by selectively
cross-
linking a polymeric resin using a controlled cross-linking process providin~
optimum
strength and wear resistance, thus diminishing or eliminating the frequency by
which
foreign particles are liberated from the implanted prosthesis, thereby
reducing the
risk of compromising the patient's health. The present invention also provides
-2-

CA 02335271 2001-02-12
= =
compositions and nlethods of injection molding prosthetic medical devices thus
rendering a less expensive, and more facile prosthetic medical device
fabrication
process.
SUMMARY OF THE INVENTION
It has been discovered that by selectively cross-linking components of
a polymeric matrix used for prosthetic medical devices, a device can be
fabricated
that possesses the required strength and wear resistance and thereby avoids or
reduces the level of polymeric material liberated from the device.
One aspect of the present invention provides for a polymeric
composition containing mixtures of cross-linked and non-crosslinked
polyolefinlc
resins blended together and ultimately formed into cured polymeric articles.
Preferably, the resulting composition and fabricated article made from the
blended
polymeric material of the present invention contains cross-linked, linear and
branched polyolefinic resins. The physical properties of the resulting
compositions
of the present invention have been found to exhibit an unexpectedly high
degree of
wear resistance and strength. As such, a preferred use of the composition of
the
present invention may be for prosthetic joints or components for devices for
shoulders, elbows, ankles, wrists, fingers, jaws, hips, knees, vertebra, and
other load-
bearing orthopedic prosthetic medical devices. Other preferred prosthetic
medical
'o devices fabricated from the composition of the present invention include
such articles
as syringes, catheters and surgical implements requiring a high degree of wear
resistance.
In another aspect of the present invention, a method of producing, the
polymeric composition is provided. In other aspects of the invention, methods
for
-3-

CA 02335271 2001-02-12
= ~
fabricating prosthetic medical devices made from the polymeric composition are
provided.
A preferred embodiment of the present invention seeks to achieve a
desirable balance of wear resistance and high tensile strength and toughness.
A
desirable balance is achieved by virtue of combining, in an integrated matrix,
cross-
linked and non-crosslinked polyolefinic polymers and resins. Once blended, the
present invention provides for the mixture to be formed in any suitable manner
or
otherwise made into prosthetic medical devices. The finished articles
preferably can
then be processed and packaged for use alone or as components of prosthetic
medical
devices.
It has been discovered that certain compositions of the present
invention allow for the blended polymeric mixture to be injection molded. This
is
possible because selected mixture combinations exhibit rheological properties
and
characteristics which are amenable to injection molding. Such mixtures exhibit
a
relatively low viscosity providing a flowable liquid to be fed into injection
molding
equipment.
Another aspect of the present invention provides for the use of
polyolefinic polymers and resins. Within the context of the present invention,
a
polymer is defined as an organic compound having repeating units of similar or
different monomers. A resin is defined herein as a partially cured polymer
having
Litility as a moldable material suitable for curing into a solid article. The
polymers
and resins of the present invention have molecular weights ranging from
between
1,000 to 10,000,000. While the invention preferably uses polvolefinic polymers
or
resins, any polymer capable of being formed into, and used as, prosthetic
devices
-4-
__-

CA 02335271 2001-02-12
may be used. Preferably, examples of such polyolefinic materials may be
polyethylene (PE), polypropylene (PP), high molecular weight polypropylene
(HMWPP), high molecular weight polyethylene (HMWPE), ultra high molecular
weight polyethylene (UHMWPE) and ultra high molecular weight polypropylene
(UHMWPP), high density polyethylene (HDPE), low density polyethylene (LDPE),
high density polypropylene (HDPP) and low density polypropylene (LDPP). Other
polymers and resins of the present invention may be polysilanes,
polyurethanes,
polyethers, polyamides, polyesters, polyalkyl acrylates, nylon, rubber and
epoxy
resins. It should be understood that the above list of polymers is not
exhaustive, and
other polymers may also be employed in the present invention.
A further aspect of the invention provides for the use of mixtures of
polymers and resins, both cross-linked and non-crosslinked varieties, to form
a single
blended matrix. It is also emphasized that not every polymer or resin
component of
the present invention need participate in, or be responsible for, the
structural integritv
or physical characteristics of the resulting prosthetic medical device, but
could also
serve to improve processing and handling, manipulations performed on the raw
materials, intermediate articles and workpieces, as well as the finished
devices.
Another aspect of the invention provides for the use of lubricants,
dyes, stabilizers and other processing compounds to be incorporated into the
polymeric matrix. These compounds enhance the polymeric mixture's
manufacturing
properties but do not necessarily contribute to the structural integrity of
the final
matrix.
In another aspect of the present invention, solid materials may be
incorporated into the polymer or resin mixtures. Such solid materials may be.
for
-5-
_

u II = 4m a, 11, CA 02335271 2005-01-06
67044-54
example, chopped carbon or glass fiber or nanotubes, carbon
black, graphite powder, talc, mica, polyamide fiber and
other fillers commonly used in the polymer industry.
In another aspect of the invention, a process is
provided whereby polyolefinic polymers or resins are sealed
in a container preferably purged of most or all oxygen and
filled with an inert atmosphere such as nitrogen.
Preferably, a powdered form of the polyolefinic polymer
resin is irradiated to effect a certain degree of cross-
linking to the polyolefinic polymer or resin. Other cross-
linking methods may also be utilized, such as those employed
in U.S. Patent No. 5,728,748, 5,650,485, 5,449,745,
5,414,049, 5,153,039, 5,160,464, 5,037,928 and U.S. Patent
Application Publication No. 2002/0093124. The irradiated
material, now possessing a certain degree of cross-linking,
is ready to be blended into a polymeric mixture, and
processed into a prosthetic device. Optionally, the present
invention also provides for further irradiation of the
finished article or workpiece. Such subsequent irradiation
may be necessary or desirable for further strengthening or
sterilization of the finished article or workpiece.
In another aspect of the present invention the
irradiated polyolefinic polymer or resin is blended with
non-irradiated polyolefinic polymer or resin into a mixture
which is then preferably processed and cured into either a
finished article or unfinished stock article. The processed
polymeric mixture may also be rendered as a powder or
pellet, for example.
According to a broad aspect of the invention,
there is provided a prosthetic medical device comprising:
a) a cured polymeric substance produced from a blended
-6-

CA 02335271 2005-11-30
67044-54
mixture of at least one cross-linked and at least one non-
cross-linked polyolefinic resin(s).
According to another broad aspect of the
invention, there is provided a polymeric composition for
fabricating prosthetic medical devices comprising: a) one
or more non-cross-linked polyolefinic resin(s); and b) one
or more cross-linked polyolefinic resin(s) whereby said
resins are blended and cured into a polymeric article.
According to a further broad aspect of the
invention, there is provided a method of fabricating a
bearing surface comprising: blending non-cross-linked
polyolefinic material with cross-linked polyolefinic
material to form a blended material; and forming the bearing
surface from the blended material.
According to a still further broad aspect of the
invention, there is provided a method of fabricating a
polyolefinic bearing surface comprising: cross-linking a
polyolefinic material; blending the cross-linked
polyolefinic material with non-cross-linked material to form
a blended material; and forming the bearing surface from the
blended material.
According to a yet further broad aspect of the
invention, there is provided a method of fabricating a
polyolefinic bearing surface comprising: providing
polyolefinic material; cross-linking a portion of the
polyolefinic material; blending the cross-linked
polyolefinic material with the non-cross-linked polyolefinic
material to form a blended material; and forming the bearing
surface from the blended material.
According to yet another broad aspect of the
invention, there is provided a prosthetic medical device
-6a-

.:....., .,_....,.,.:_. ..,,..i i-.. .. ,.. . .. . . ..<. ,.,,, . ..,..... .._
....,,.. .. a ._..._,.. :....:.... ...__.... .. , ..... . ... .... :...... . .
. _. : ... .. . ..
CA 02335271 2005-11-30
67044-54
fabricated by a process comprising the steps of:
a) irradiating at least one polymeric resin in the presenco
of an inert atmosphere to yield a cross-linked irradiated
polymeric resin; b) blending at least one non-irradiated
polymer with said at least one irradiated polymeric resin to
form a blended mixture; c) forming a cured workpiece from
said blended mixture; and d) shaping said workpiece into a
prosthetic medical device.
According to still another broad aspect of the
invention, there is provided a prosthetic medical device
fabricated by a process comprising the steps of:
a) irradiating at least one polymeric resin in the presence
of an inert atmosphere to yield a cross-linked irradiated
polymeric resin; b) blending at least one non-irradiated
polymer with said at least one irradiated polymeric resin to
form a blended mixture; and c) forming a prosthetic medical
device by injection molding the blended mixture.
According to an even further broad aspect of the
invention, there is provided a prosthetic medical device
having improved wear resistance comprising: an irradiated
polymer and a non-irradiated polymer blended as a mixture,
injection molded and cured into a finished article or
workpiece.
According to still another broad aspect of the
invention, there is provided a prosthetic medical device
fabricated by a process comprising the steps of:
a) irradiating at least one polyolefinic material in the
presence of an inert atmosphere to yield a cross-linked
irradiated polyolefinic material; b) blending at least one
non-irradiated polyolefinic material with the at least one
irradiated polyolefinic material to form a blended material;
-6b-

CA 02335271 2005-11-30
67044-54
and c) forming the prosthetic medical device from the
blended material.
According to a still further broad aspect of the
invention, there is provided a prosthetic medical device
fabricated by a process comprising the steps of:
a) irradiating at least one polyolefinic material in the
presence of an inert atmosphere; b) stabilizing the at least
one irradiated polyolefinic material to yield a cross-linked
irradiated polyolefinic material; c) blending at least one
non-irradiated polyolefinic material with the at least one
cross-linked irradiated polyolefinic material; and d) forming
the prosthetic medical device from the blended material.
According to a yet further broad aspect of the
invention, there is provided a prosthetic medical device
fabricated by a process comprising the steps of:
a) irradiating at least one polyolefinic material in the
presence of an inert atmosphere; b) forming cross-links
between free radicals by using heat in an inert atmosphere
to yield a cross-linked irradiated polyolefinic material;
c) blending at least one non-irradiated polyolefinic
material with the at least one cross-linked irradiated
polyolefinic material; and d) forming the prosthetic medical
device from the blended material.
DESCRIPTION OF THE FIGURES
FIG. 1 is a representation of data plotting wear
rate (mg/mil) vs. percentage of cross-linked polymer
incorporated into the final matrix.
-6c-

CA 02335271 2001-02-12
FIG. 2 is a representation of data plotting wear rate (mgimil) vs.
percentage of cross-linked polymer incorporated into the final matrix.
FIG. 3 is a representation of a process flow chart diagramming the
steps involved in molding the polymeric blends.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE
INVENTION
The compositions according to a preferred embodiment of the present
invention are blends of irradiated or otherwise cross-linked polyolefinic
polymers or
resins combined with linear or uncross-linked polyolefinic polymers or resins.
These
compositions of the present invention improve the durability of articles
fabricated
therefrom by increasing the wear resistance in load-bearing environments. See
FIGS.
I and 2.
The cross-linked, linear and/or branched polyolefinic polymers or
1~ resins may be the same or different monomeric starting materials. The
blended
polymer or resin mixture may then be processed and cured directly into
prosthetic
devices by injection molding, or alternatively into stock articles or
workpieces that
may be formed into the desired shape in the future. The blended polymer may
also
be produced in a powder, tlake or pellet to be used for future processing.
Generally, the composition of the present invention may be blended to
contain from about 1% to about 99% by weight, based on the total weight of the
composition, of a polyolefinic polymer or resin powder which has been
irradiated
with radiation for a sufficient period of time to cause cross-linking of the
polyolefinic
polymer or resin. In a preferred embodiment, a range of about 1- 1,000 Mrads
mav
be used to irradiate the polyolefin. In an even niore preferred embodiment of
the
-7-

CA 02335271 2001-02-12
~ =
present invention, 1-100 Mrads may be used, and in the most preferred range 5-
20
Mrads may be used.
Preferred polymers for irradiation may be selected from one or nlore
of the following: polyethylene, polypropylene and/or branched derivatives
thereof.
In a preferred embodiment, the polymer type is a polyethylene. The polyolefins
of
the present invention may have a molecular weight ranging between about 1000
to
about 10,000,000. Preferably, UHMWPE may be used in the present invention. The
ratio of irradiated and non-irradiated polyolefin may range from about 1- 99%
irradiated polyolefin. In a preferred embodiment, a 50:50 mixture of
irradiated and
non-irradiated polyolefinic powder may be blended together. An even mor~
preferred embodiment of the present invention provides for the mixture of a
30:70
blend of irradiated to non-irradiated polyolefinic powder.
In yet another preferred embodiment a blend of UHMWPE powder is
blended with HDPE powder. In this embodiment, either the UHMWPE or the HDPE
ji may be cross-linked. In an even more preferred embodiment of the present
invention,
the UHMWPE is cross-linked then blended with uncross-linked HDPE. A preferred
ratio blend is 1:99 % UHMWPE to HDPE. In a more preferred embodiment, the
ratio may be 20:80 UHMWPE to HDPE. The most preferred ratio is 30:70
UHMWPE to HDPE. This mixture is preferably injection molded into a prosthetic
device.
In another aspect of the invention, a method is provided to prepare the
above described polymeric compositions. In such a method, a selected
polyoletinic
polymer or resin is packa~ed in an air-tight container which is transparent or
opaque.
The container is purged of at least most of the ambient oxygen and,
preferably, filled
-8-

n. x 1
CA 02335271 2005-01-06
67044-54
with an inert atmosphere such as nitrogen or argon. The filled package is then
preferably irradiated using gamma ray, x-ray or electron beam irradiation. The
total
dose may vary according to the amount of cross-linking desired. After
irradiation,
the powder is preferably heated to a temperature below, at, or above the
melting point
~ of the polymeric material and annealed for a selected period of time at the
elevated
temperature. The material is then preferably cooled or allowed to cool. The
irradiated material is then mixed with non-irradiated polyolefinic linear
polymer or -
resin. The weight percent for the mixture will vary according to the desired
amount
of cross-linking to be contained in the final product as discussed above. The
mixing
may be performed in a blender, rotary mixer, tumbling mill, or any other
suitable
blending or mixing device. The mixed powder is then extruded or molded into
material stock. See FIG. 3. Alternatively, the mixed powder may be injection
molded into the desired shape. If necessary, the final component is then
machined
into the desired shape, cleaned and packaged. The packaged article may then be
sterilized by the use of a non-radiation.method such as gas plasma or ethylene
oxide,
or by another irradiation treatment such as those set forth in the above
patents and
applications.
In a. preferred embodiment of the composition, UHMWPE is
packaged in a substantially oxygen-free environment. The packaged material is
then
irradiated for a total dose of 10-12 Mrads. The package is then annealed at an
elevated temperature ranging from approximately 100 C - 150 C for three days,
followed by ambient cooling. The irradiated material is then blended with non-
cross-
linked UHMWPE or HDPE to a ratio of approximately 5-30% irradiated powder.
See FIG. 2. The powder blend is then preferably melted into a liquid which
exhibits
-9-

CA 02335271 2001-02-12
rheological properties and characteristics suitable for injection molding
applications.
The liquid product is then fed into injection molding equipment vvhich
correspondingly renders the polymer into a finished article or preformed bar
or block.
The finished article may then be packaged and sterilized using ethylene oxide
or gas
plasma. The preformed bar or block may be further processed into a finished
article.
In another preferred embodiment, additives such as lubricants, dyes,
stabilizers and other process enhancing compounds are incorporated into the
polymeric mixture. Such compounds may not necessarily enhance the strength or
stnictural integrity of the final polymeric matrix, but do aid in the
manufacturing
process or enhance the overall appearance of the finished article. Examples of
the5e
compounds may be long chain fatty acids and their salts, organic and inorganic
coloring agents, free radical inhibitors, pH buffering agents and other
materials
known to enhance processing of polymers within the polymer industry.
In another preferred embodiment of the present invention, solid
t~ materials may be incorporated into the polymer or resin mixtures. Such
solid
materials may be, for example, chopped carbon or glass fiber or nanotubes,
carbon
black, graphite powder, talc, mica, polvamide fiber and other fillers commonly
used
in the polymer industry. As is known in the polymer industry, such fillers may
be
advantageously added to a polymer niatrix for the purposes of enhancing
strength,
durability, bulk density, machineablity of the resulting polymeric article.
Of, course
the above list is not exhaustive and other uses of the fillers may also be
contemplated.
In another aspect of the invention the polymeric material is prepared
as discussed immediately above, then compression molded or extruded into a
-10-

CA 02335271 2001-02-12
~ =
preformed bar or block. The preformed articles may be shaped into finished
prosthetic medical devices in the future.
EXAMPLES
EXAMPLE I
GUR1050 (e.g., UHMWPE having average molecular weight of
4,000,000 -6,000,000) powder was irradiated at 12 Mrads in a nitrogen
atmosphere
and stabilized in a nitrocren atmosphere at 100 C for three days. Several
mixtures of
the cross-linked irradiated powder were prepared by blend-mixing with non-
irradiated powder in the following proportions
SAMPLE % IRRADIATED, % NON-
NUMBER NUMBER CROSSLINKED IRRADIATED
1 5 95
2 10% 90%
3 30% 70%
4 100 /o 0%
A reference sample (Sample 0) containing 0% irradiated and 100%
un-irradiated powder was also prepared.
The powder samples were compression molded into blanks which
were machined into cups and then subjected to a hip simulator test to
determine the
wear rate of the material.
The results were as follows:
SAMPLE WEAR RATE ,% REDUCTION % CROSSLINKED
NUMBER (mm3i 10' cycles) (from reference)
0 (Reference) 102.1 0 0
1 23.1 77.4 5
2 10.6 89.6 10
3 5.8 94.3 30
4 1.9 98.1 100
-ll-

CA 02335271 2001-02-12
The results show that a mixture containing as little as 5% irradiated
material produces an almost 77% reduction in the wear rate. In mixtures
containing
30 % irradiated material, the wear reduction is almost 94%. Therefore,
mixtures
containing from about 5% to about 30% irradiated material demonstrate an
optimum
wear reduction versus cost as the cost of production of the material increases
as the
percentage irradiated material content increases.
EXAMPLE 11
GUR1050 (e.g., UHMWPE having average molecular weight of
4,000,000 -6,000,000) powder was irradiated at 12 Mrads in a nitrogen
atmosphere
and stabilized in a nitrogen atmosphere at 100 C for three days. A mixture of
the
cross-linked irradiated powder was prepared by blend-mixing with HDPE non-
irradiated powder in the following proportions:
SAMPLE % IRRADIATED, % NON-
NUMBER CROSSLINKED IRRADIATED
1 0 100 (UHMWPE)
2 30 (UHMWPE) 70 (HDPE)
A reference sample (Sample 1) containing 01,% irradiated and 100% non-
irradiated
powder was also prepared.
The powder samples were injection molded into blanks which were
machined into cups and then subjected to a hip simulator test to determine the
wear
rate of the material.
-12-

CA 02335271 2001-02-12
= ~
The results were as follows:
SAMPLE WEAR RATE % REDUCTION % CROSSLINKED
NUMBER (mm'/10" cycles) (from reference)
1 (Reference) 102.1 0 0
2 4.1 95.9 30
While the foregoing description of examples and figures illustrates
preferred embodiments of the various methods, compositions and articles of
manufacture in accordance with the present invention, it should be appreciated
that
the invention also covers various permutations of the foregoing described
features,
and that certain modifications may be made in the foregoing without departing
from
the spirit and scope of the present invention which is defined by the claims
set forth
immediately hereafter.
-13-

Representative Drawing

Sorry, the representative drawing for patent document number 2335271 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (new Act pat) 2021-02-12
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Change of Address or Method of Correspondence Request Received 2018-03-28
Grant by Issuance 2008-07-15
Inactive: Cover page published 2008-07-14
Pre-grant 2008-04-02
Inactive: Final fee received 2008-04-02
Notice of Allowance is Issued 2008-01-25
Letter Sent 2008-01-25
Notice of Allowance is Issued 2008-01-25
Inactive: IPC assigned 2007-12-19
Inactive: First IPC assigned 2007-12-19
Inactive: IPC assigned 2007-12-19
Inactive: IPC assigned 2007-12-19
Inactive: IPC assigned 2007-12-13
Inactive: First IPC assigned 2007-12-13
Inactive: Approved for allowance (AFA) 2007-11-01
Amendment Received - Voluntary Amendment 2006-11-22
Inactive: S.30(2) Rules - Examiner requisition 2006-06-16
Inactive: IPC from MCD 2006-03-12
Amendment Received - Voluntary Amendment 2005-11-30
Inactive: S.30(2) Rules - Examiner requisition 2005-05-31
Amendment Received - Voluntary Amendment 2005-01-06
Inactive: S.30(2) Rules - Examiner requisition 2004-07-06
Inactive: S.29 Rules - Examiner requisition 2004-07-06
Application Published (Open to Public Inspection) 2001-08-29
Inactive: Cover page published 2001-08-28
Inactive: IPC assigned 2001-04-02
Inactive: First IPC assigned 2001-04-02
Inactive: Filing certificate - RFE (English) 2001-03-16
Letter Sent 2001-03-16
Application Received - Regular National 2001-03-12
Request for Examination Requirements Determined Compliant 2001-02-12
All Requirements for Examination Determined Compliant 2001-02-12

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2007-12-13

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
HOWMEDICA OSTEONICS CORP.
Past Owners on Record
AARON ESSNER
AIGUO WANG
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2001-02-11 1 16
Description 2001-02-11 13 463
Claims 2001-02-11 6 190
Drawings 2001-02-11 2 43
Claims 2005-01-05 16 545
Description 2005-01-05 16 590
Claims 2005-11-29 16 558
Description 2005-11-29 16 593
Claims 2006-11-21 16 555
Courtesy - Certificate of registration (related document(s)) 2001-03-15 1 113
Filing Certificate (English) 2001-03-15 1 162
Reminder of maintenance fee due 2002-10-15 1 109
Commissioner's Notice - Application Found Allowable 2008-01-24 1 164
Correspondence 2008-04-01 1 40